Bisphenol A concentration-dependently increases human granulosa-lutein cell matrix metalloproteinase-9 (MMP-9) enzyme output

Reproductive Toxicology

Volumn 25, Issue 4, 2008, Pages 420-425

  Dominguez, Miguel A ^a,b   Petre, Maria A ^a   Neal, Michael S ^a   Foster, Warren G ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSIDAD AUTÓNOMA DE TAMAULIPAS   (Mexico)

Author keywords

Bisphenol A; Folliculogenesis; Granulosa cells; Matrix metalloproteinases; MMP 9

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; GELATINASE B;

ADULT; ARTICLE; BLOOD LEVEL; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FERTILIZATION IN VITRO; GRANULOSA CELL; HUMAN; HUMAN CELL; LUTEAL CELL; MALE; OOCYTE RETRIEVAL;

ADULT; CELL SURVIVAL; CELLS, CULTURED; ENVIRONMENTAL POLLUTANTS; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; LUTEAL CELLS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PHENOLS;

EID: 47249130708     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2008.05.059     Document Type: Article

References (39)

1. Andersen C.Y., and Byskov A.G. Estradiol and regulation of anti-Müllerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid. J Clin Endocrinol Metab 91 (2006) 4064-4069
2. Andersen C.Y., Humaidan P., Ejdrup H.B., Bungum L., Grøndahl M.L., and Westergaard L.G. Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or hCG for ovulation induction. Hum Reprod 21 (2006) 2126-2130
3. Bagavandoss P. Differential distribution of gelatinases and tissue inhibitor of metalloproteinase-1 in the rat ovary. J Endocrinol 158 (1998) 221-228
4. Beckers N.G.M., Platteau P., Eijkemans M.J., Macklon N.S., de Jong F.H., Devroey P., et al. The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women. Eur J Endocrinol 155 (2006) 355-363
5. Calafat A.M., Kuklenyik Z., Reidy J.A., Caudill S.P., Ekong J., and Needham L.L. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113 (2005) 391-395
6. Fatemi H.M., Kolibianakis E.M., Camus M., Tournaye H., Donoso P., Papanikolaou E., et al. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial. Hum Reprod 21 (2006) 2628-2632
7. Fatemi H.M., Popovic-Todorovic B., Papanikolaou E., Donoso P., and Devroey P. An update of luteal phase support in stimulated IVF cycles. Hum Reprod Update 13 (2007) 581-590
8. Fernandez M.F., Arrebola J.P., Taoufiki J., Navalón A., Ballesteros O., Pulgar R., et al. Bisphenol-A and chlorinated derivatives in adipose tissue of women. Reprod Toxicol 24 (2007) 259-264
9. Goldman S., and Shalev E. The role of the matrix metalloproteinases in human endometrial and ovarian cycles. Eur J Obstet Gynecol Reprod Biol 111 (2003) 109-121
10. Gray G.M., Cohen J.T., Cunha G., Hughes C., McConnell E.E., Rhomberg L., et al. Weight of the evidence evaluation of low-dose reproductive and developmental effects of bisphenol A. Hum Ecol Risk Assess 10 (2004) 875-921
11. Huang H.F., Hong H., Tan Y., and Sheng J.Z. Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis. Fertil Steril 81 (2004) 1235-1239
12. Hunt P.A., Koehler K.E., Susiarjo M., Hodges C.A., Ilagan A., Voigt R.C., et al. Bisphenol A exposure causes meiotic aneuploidy in the female mouse. Curr Biol 13 (2003) 546-553
13. Ikezuki Y., Tsutsumi O., Takai Y., Kamei Y., and Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod 17 (2002) 2839-2841
14. Jin H., and Audus K.L. Effect of bisphenol A on drug efflux in BeWo, a human trophoblast-like cell line. Placenta 26 Suppl. A (2005) S96-S103
15. Koehler K.E., Voigt R.C., Thomas S., Lamb B., Urban C., Hassold T., et al. When disaster strikes: rethinking caging materials. Lab Animal 32 (2003) 32-36
16. Lewandowski K.C., Komorowski J., O'Callaghan C.J., Tan B.K., Chen J., Prelevic G.M., et al. Increased circulating levels of matrix metalloproteinase-2 and -9 in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 91 (2006) 1173-1177
17. Lobb D.K., and Younglai E.V. A simplified method for preparing IVF granulosa cells for culture. J Assist Reprod Genet 23 (2006) 93-95
18. Maffini M.V., Rubin B.S., Sonnenschein C., and Soto A.M. Endocrine disruptors and reproductive health: the case of bisphenol-A. Mol Cell Endocrinol 254-255 (2006) 179-186
19. McIntush E.W., and Smith M.F. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in ovarian function. Rev Reprod 3 (1998) 23-30
20. Mlynarčíková A., Kolena J., Ficková M., and Scsuková S. Alterations in steroid hormone production by porcine ovarian granulosa cells caused by bisphenol A and bisphenol A dimethacrylate. Mol Cell Endocrinol 244 (2005) 57-62
21. Ouchi K., and Watanabe S. Measurement of bisphenol A in human urine using liquid chromatography with multi-channel coulometric electrochemical detection. J Chromatogr B: Anal Technol Biomed Life Sci 780 (2002) 365-370
22. Rasier G., Toppari J., Parent A.S., and Bourguignon J.P. Female sexual maturation and reproduction after prepubertal exposure to estrogens and endocrine disrupting chemicals: a review of rodent and human data. Mol Cell Endocrinol 254-255 (2006) 187-201
23. Rubin B.S., Murray M.K., Damassa D.A., King J.C., and Soto A.M. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect 109 (2001) 675-680
24. Sasaki N., Okuda K., Kato T., Kakishima H., Okuma H., Abe K., et al. Salivary bisphenol-A levels detected by ELISA after restoration with composite resin. J Mater Sci Mater Med 16 (2005) 297-300
25. Savabieasfahani M., Kannan K., Astapova O., Evans N.P., and Padmanabhan V. Developmental programming: differential effects of prenatal exposure to bisphenol-A or methoxychlor on reproductive function. Endocrinology 147 (2006) 5956-5966
26. Shalev E., Goldman S., and Ben-Shlomo I. The balance between MMP-9 and MMP-2 and their tissue inhibitor (TIMP)-1 in luteinized granulose cells: comparison between women with PCOS and normal ovulatory women. Mol Hum Reprod 7 (2001) 325-331
27. Smith M.F., Ricke W.A., Bakke L.J., Dow M.P., and Smith G.W. Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors. Mol Cell Endocrinol 191 (2002) 45-56
28. Sugiura-Ogasawara M., Ozaki Y., Sonta S., Makino T., and Suzumori K. Exposure to bisphenol A is associated with recurrent miscarriage. Hum Reprod 20 (2005) 2325-2329
29. Suzuki A., Sugihara A., Uchida K., Sato T., Ohta Y., Katsu Y., et al. Developmental effects of perinatal exposure to bisphenol-A and diethylstilbestrol on reproductive organs in female mice. Reprod Toxicol 16 (2002) 107-116
30. Takai Y., Tsutsumi O., Ikezuki Y., Hiroi H., Osuga Y., Momoeda M., et al. Estrogen receptor-mediated effects of a xenoestrogen, bisphenol A, on preimplantation mouse embryos. Biochem Biophys Res Commun 270 (2000) 918-921
31. Takeuchi T., and Tsutsumi O. Serum bisphenol A concentrations showed gender differences, possibly linked to androgen levels. Biochem Biophys Res Commun 291 (2002) 76-78
32. Takeuchi T., Tsutsumi O., Ikezuki Y., Takai Y., and Taketani Y. Positive correlation between androgen and the endocrine-disruptor bisphenol A, in normal women and women with ovarian dysfunction. Endocrine J 51 (2004) 165-169
33. Teeguarden J.G., Waechter J.M., Clewell H.J., Covington T.R., and Barton H.A. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol a: a physiologically based pharmacokinetic approach. Toxicol Sci 85 (2005) 823-838
34. Toda K., Miyaura C., Okada T., and Shizuta Y. Dietary bisphenol A prevents ovarian degeneration and bone loss in female mice lacking the aromatase gene (Cyp19). J Biochem 269 (2002) 2214-2222
35. Tsutsumi O. Assessment of human contamination of estrogenic endocrine-disrupting chemicals and their risk for human reproduction. J Steroid Biochem Mol Biol 93 (2005) 325-330
36. Welshons W.V., Thayer K.A., Judy B.M., Taylor J.A., Curran E.M., and vom Saal F.S. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect 111 (2003) 994-1006
37. Welshons W.V., Nagel S.C., and vom Saal F.S. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147 Suppl. (2006) S56-S69
38. 2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environ Health Perspect 113 (2005) 431-439
39. Ye X., Kuklenyik Z., Needham L.L., and Calafat A.M. Measuring environmental phenols and chlorinated organic chemicals in breast milk using automated on-line column-switching-high performance liquid chromatography-isotope dilution tandem mass spectrometry. J Chromatogr B: Anal Technol Biomed Life Sci 831 (2006) 110-115